Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$224,359
-$81,887 QoQ
Shares Held
4,680
-22.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#991
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COZAD ASSET MANAGEMENT INC holds $35,468,302 across 7 Drug Manufacturers - General names. NVO ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,746 | $28,481,667 | |
| 2 | JNJ |
Johnson & Johnson
|
17,475 | $4,438,125 | |
| 3 | PFE |
Pfizer Inc
|
35,997 | $866,807 | |
| 4 | AMGN |
Amgen Inc
|
1,667 | $603,654 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,012 | $506,876 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,019 | $346,814 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
4,680 | $224,359 |
All Filings in NVO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,359 | 4,680 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $306,246 | 6,019 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $525,823 | 9,476 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $709,456 | 10,279 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $992,228 | 14,289 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,625,605 | 18,898 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,845,892 | 23,901 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,980,553 | 20,881 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,108,071 | 16,418 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,569,336 | 15,170 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $989,609 | 10,882 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $777,916 | 4,807 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $819,889 | 5,152 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $702,143 | 5,188 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $520,467 | 5,224 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $582,110 | 5,224 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $601,224 | 5,414 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $590,688 | 5,274 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $506,356 | 5,274 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $441,802 | 5,274 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $355,573 | 5,274 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $380,961 | 5,454 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $378,671 | 5,454 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $357,127 | 5,454 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $328,330 | 5,454 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||